ABSTRACT Airway responsiveness to histamine in man may be determined by the smooth muscle sensitivity to histamine or to the interaction between vagal nerve input and smooth muscle sensitivity. We have compared in vivo responsiveness to histamine with in vitro smooth muscle sensitivity to histamine in 20 non-asthmatic patients and one asthmatic patient undergoing thoracic surgery. Histamine responsiveness was assessed in the first 10 non-asthmatics without atropine pretreatment, in the second 10 after atropine pretreatment, and in the asthmatic patient both with and without atropine. In vivo responsiveness was also measured in 10 normal subjects and 10 asthmatic patients not undergoing surgery. Results were expressed as the provocation concentration (PC) causing a decrease in FEVy of 20% (PC2OFEV1) and in specific airways conductance of 35% (PC35sGaw), and in terms of maximal expiratory flow at 35% vital capacity, measured from the partial (V35(p)) and complete (V3 c) flow volume curves of 35% (PC3 V3fP); PC35V35C). In vitro smooth muscle sensitivity to istamine of bronchial tissue obtained at thoracotomy was expressed as the concentration causing a 50% maximum contraction (EC,,) and as the maximum tension generated. There was considerable variation between patients in the in vivo responsiveness but a relatively narrow range for in vitro responses. There was no significant correlation between in vivo responsiveness, either with or without atropine pretreatment, and in vitro results. The asthmatic patient showed hyperresponsiveness in vivo but not in vitro. These results suggest that in vitro airway smooth muscle sensitivity to histamine is not the sole determinant of in vivo airway responsiveness and that this lack of relationship is not explained by the influence of vagal nerve input on in vivo measurements. The results in the asthmatic patient suggest that airway hyperresponsiveness may be an in vivo phenomenon which is not related to a primary abnormality of airway smooth muscle.
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The bronchoconstrictor response to a stimulus such as histamine requires contraction of airway smooth muscle,' which is under nervous, humoral and intrinsic muscular control.2 4 Patients with asthma5 and chronic obstructive bronchitis6I show greater airway responsiveness than normal subjects. The cause of this increased responsiveness is unknown. Histamine produces bronchoconstriction by acting directly on airway smooth muscle H, receptors89 and also possibly reflexly via vagal pathways.'0 Thus airway hyperresponsiveness to histamine may be due to increased sensitivity of the smooth muscle itself, or may be related to an abnormality of the nervous or humoral control (or both) of the airways." If the primary abnormality resides in the smooth muscle then increased in vivo airway responsiveness to histamine would be expected to be associated with enhanced in vitro smooth muscle sensitivity. Alternatively, if in vivo airway responsiveness to histamine is modified by an interaction between vagal nerve input and smooth muscle sensitivity, then a relationship between in vivo and in vitro responses may be apparent only after cholinergic blockade with atropine.
In this study we ND-not done. Table 2 Characteristics ofnormal subjects and asthmatic patents (means with standard deviations in parentheses)
(% pred) Normal(n= 10) 53 (8) 171 (9) 2.96 (0.8) 112 (14) 101 (15) Asthmatic (n = 10) 60 (9) 165 (8) 11.7 . The next day rings of bronchi were dissected out and sectioned. These strips of tissue were then suspended under a resting tension of 1.5-2.0 g in 20 ml organ baths containing Krebs-Henseleit solution at 37°C bubbled with 5% carbon dioxide in oxygen. After 60 minutes equilibration tissues were washed three times. Change in isometric tension was measured by Grass force displacement transducers (FT03C) and recorded on a Grass (model 7) polygraph.
The normality of the bronchial strips and reproducibility of their response to histamine was assessed by adding histamine (10 ,umol/l) on two separate occasions 30 minutes apart. A cumulative concentration-response study was carried out by adding increasing concentrations of histamine from 0.1 to 400 ,umol/l from each addition of histamine being given while the preceding was having its peak effect. The concentration of histamine producing 20% (EC,0) and 50% (EC50) of the maximal contraction was calculated. The maximum tension generated by each strip was determined and expressed in g tension per mg wet weight of tissue (tissue weight was measured at the end of each experiment). The mean baseline FEVy expressed as a percentage of the predicted value was significantly higher in the non-smoking controls (112%) than in the other groups (table 2) . There was no significant dif- Airway responsiveness to histamine in man ference between the asthmatic patients (75%) and the surgical patients who did or did not receive pretreatment with atropine (84% and 75% respectively). Atropine produced significant increases in FEV, (7. 3 (SD 4.5%)), sGaw (112% (84%)), V3ap (55% (28%)), and 3y (32% (41%)). The postatropine baseline FEVN(82.0 + 17) was, however, still significantly lower than that of the non-smoking controls and was not significantly different from the other two groups.
In the surgical group not pretreated with atropine baseline FEVy (percentage predicted) correlated with PC20FEV, ( ,umol/l and a range of 1.0-14.0 ,mol/l. The mean maximum tension generated was 13.8 (1.6) (range 4.2-30.3) g/mg wet weight.
COMPARISON OF IN VIVO AND IN VITRO RESPONSIVENESS TO HISTAMINE
There was no significant correlation between any of the measurements of in vivo and in vitro responsiveness to histamine in either of the surgical groups.
The lack of relationship of PC20FEV, and PC35sGaw with EC5O is illustrated for the surgical patients who did not receive pretreatment with atropine in figure  2 , and for those who did in figure 3 .
The asthmatic patient who underwent surgery did not exhibit increased in vitro smooth muscle responsiveness to histamine (EC,0 2.3 ,umol/l; maximum tension generated 18.4 g/mg wet weight).
Discussion
In this study of 41 subjects we found a 1000 fold variation in airway responsiveness to histamine. The surgical patients, from whom bronchial tissue was obtained, were more responsive than non-smoking normal subjects of a similar age, but less responsive than the asthmatic patients. Cigarette smoking, chronic bronchitis, and airflow obstruction may all 265 have contributed to the increase in responsiveness in the surgical group. Cigarette smoking has been associated with increased non-specific airway responsiveness in symptom free subjects without airflow obstruction,'8 though this finding has not been confirmed by others.'9 Eight patients had chronic bronchitis, which has been shown to be related to hyperresponsiveness both in those with6 7 20 21 and in those without airflow obstruction. 22 In the surgical group there was a significant relationship between baseline lung function and PC20FEVI, but this was not true for the normal subjects or for the asthmatic patients. This suggests that baseline airway calibre may be a more important determinant of airway responsiveness in smokers than in patients with asthma.
We do not know whether the presence of a bronchial neoplasm has any effect on airway responsiveness; but a comparison of responsiveness, made by Bahous and coworkers,2' in patients similar to ours but without a neoplasm showed a range of airway responsiveness similar to ours.
In this study there was no significant relationship between in vivo airway responsiveness to histamine and in vitro measurements of smooth muscle responsiveness. In vitro measurements were made on tissues which had been washed thoroughly, stored overnight in fresh oxygenated saline at low temperature, and washed thoroughly again before testing. This A common feature of asthma is the increased airway responsiveness to varied stimuli. This appears to be non-specific for several triggers since in a given individual with asthma the airway response to one stimulus usually correlates well with that to another. Individuals highly sensitive to histamine are also generally more sensitive to methacholine,28 prostaglandin F2,,,2, cold air,30 and exercise.3' One mechanism which could explain this non-specific hyperresponsiveness would be an abnormality in airway smooth muscle." In vitro hyperresponsiveness of airway smooth muscle could be reflected in a lower ECSO value or an increase in the maximum tension generated by each smooth muscle strip, or both. In this study, however, the one asthmatic patient undergoing surgery showed the expected in vivo hyperresponsiveness to histamine but did not show increased in vitro responsiveness as assessed by EC50 or maximum tension generated. Since the maximum tension generated but not the EC5, could be affected by the quantity of smooth muscle present in each strip, it is possible that by chance there was less smooth muscle in the bronchial strip from the asthmatic patient, and that this was masking a real increase in maximum tension generated. To try to overcome this problem the maximum tension generated was expressed per unit mass of tissue and this failed to alter the conclusion reached. The size and number of smooth muscle cells present in each bronchial strip would have to be determined accurately before a defect in airway smooth muscle function as a cause of airway hyperresponsiveness could be completely ruled out.
In a similar study using methacholine as an agonist, a patient who had features of asthma, including in vivo airway hyperresponsiveness, did not show increased in vitro smooth muscle responsiveness."
Other studies have examined in vitro sensitivity of Roberts, Rodger, Thomson human bronchial smooth muscle without comparing it to in vivo responsiveness.3234 Dahlen and coworkers32 examined bronchial strips, obtained at thoracotomy for bronchial carcinoma, from two patient with asthma who were allergic to birch pollen and found that the bronchial strips from these patients were no more sensitive to histamine or leukotrienes than were strips from non-asthmatic subjects. A study of postmortem tissue from three asthmatic patients who died during acute asthmatic attacks showed no difference between the sensitivity of the asthmatic airway and that of bronchi obtained from normal subjects when both histamine and carbachol were used as agonists. 33 
